GYRE earnings: a positive outcome, +7.2%

On May 11, 2020, GYRE THERAPEUTICS, INC. reached its earnings. The result was a positive outcome, and the stock moved +7.2% in the window around the event. It had already run +27.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.